logo

For the Inventor, By the Inventor

Basel, Switzerland

Andrea Cesura

USPTO Granted Patents = 13 

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 92(Granted Patents)


Location History:

  • Basel, CH (1999 - 2003)
  • Crans-pres-Celigny, CH (2003 - 2010)

Company Filing History:

goldMedal13 out of 4,948 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1999-2010

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7642283 - Mitochrondrial permeability transition pore affinity labels and modulators (2010-01-05),
2. 7101917 - Mitochrondrial permeability transition pore affinity labels and modulators (2006-09-05),
3. 6903095 - Phthalimido derivatives and a process for their preparation (2005-06-07),
4. 6818774 - Isoquinoline derivatives (2004-11-16),
5. 6667327 - Pyridine amido derivatives (2003-12-23),
6. 6660736 - Phthalimido derivatives and a process for their preparation (2003-12-09),
7. 6642247 - Di-or triaza-spiro [4,5] decane derivatives (2003-11-04),
8. 6166209 - Piperidine derivatives (2000-12-26),
9. 6113527 - Diaza-spiro[3,5] nonane derivatives (2000-09-05),
10. 6071925 - 1,3,8-triazaspiro[4,5]decan-4-one derivatives (2000-06-06),
11. 6043366 - 1,3,8,-triaza spiro (4,5)decan-4-on derivatives (2000-03-28),
12. 5958910 - Use of N-(4-aryl-thiazol-2-yl)-sulfonamides (1999-09-28),
13. 5877193 - Use of N-(4-aryl-thiazol-2-yl)-sulfonamides (1999-03-02),

Title: Andrea Cesura: Innovator in Mitochondrial Research

Introduction: Andrea Cesura, a talented inventor based in Basel, Switzerland, has made significant contributions to the field of mitochondrial research. With 13 patents to her name, Cesura's work revolves around the complexities of mitochondrial permeability transition pores, a critical component of cellular function and health.

Latest Patents: Among her latest patents are "Mitochondrial Permeability Transition Pore Affinity Labels and Modulators." These patents elucidate methods of utilizing compounds of general formulas I and II as modulators and affinity labels of the MPTP complex. Furthermore, Cesura outlines techniques for modulating the activity of the MPTP complex, methods for determining the presence of a component of the MPTP complex, and strategies for identifying active agents that interact with the VDAC1 component to modulate the activity of the MPTP complex. The disclosure of novel compounds of general formulas I and II adds to the innovative landscape of her research.

Career Highlights: Andrea Cesura's career is marked by her dedication to pioneering mitochondrial research at Hoffmann-La Roche Inc. Her work has positioned her as a key figure in biochemistry and molecular biology, providing essential insights that could lead to breakthroughs in understanding and treating diseases related to mitochondrial dysfunction.

Collaborations: In her role at Hoffmann-La Roche Inc., Cesura collaborates with esteemed colleagues, including Stephan Rover and Geo Adam. These partnerships reflect her commitment to advancing scientific knowledge and innovation within her field.

Conclusion: Andrea Cesura's contributions to mitochondrial research through her patents and collaborations underscore her importance as an inventor. Her work not only enhances our understanding of mitochondrial permeability transition pores but also paves the way for future innovations in medicine and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…